NaCl is one of 122 small molecule programs targeting Fatigue. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
114 competitors in Kidney Transplant
Ultomiris
Kerendia
NaCl
Felzartamab
Biological/vaccine
Zemplar
Radicava
Cysteine Hydrochloride
Sensipar
Epogen
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources